Collegium Pharmaceutical (COLL) Assets Average (2015 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Assets Average of $1.7 billion for Q1 2026, little changed year-over-year from $1.6 billion in Q1 2025, and up 1.37% quarter-over-quarter from $1.6 billion in Q4 2025.
Collegium Pharmaceutical (COLL) Assets Average (2015 - 2026) Analysis & Trends
Collegium Pharmaceutical's Assets Average history runs 12 years deep, the most recent figure standing at $1.7 billion for Q1 2026.
- In Q1 2026, Assets Average changed 0.42% year-over-year to $1.7 billion; the TTM figure through Mar 2026 stood at $1.7 billion (changed 0.42% YoY), while the FY2025 annual figure was $1.7 billion, up 18.3% from the prior year.
- Assets Average for Q1 2026 stood at $1.7 billion, up from $1.6 billion in the prior quarter.
- The five-year high for Assets Average was $1.7 billion in Q1 2026, with the low at $969.1 million in Q1 2022.
- The 5-year median for Assets Average is $1.2 billion (2022), against an average of $1.3 billion.
- The sharpest annual moves came in 2022 and 2024: Assets Average jumped 83.24% in 2022, then fell 10.73% in 2024.
- Collegium Pharmaceutical's Assets Average stood at $1.2 billion in 2022, then dropped by 2.28% to $1.2 billion in 2023, then soared by 42.13% to $1.6 billion in 2024, then fell by 1.05% to $1.6 billion in 2025, then rose by 1.37% to $1.7 billion in 2026.
- Business Quant data shows COLL's Assets Average at $1.7 billion in Q1 2026, $1.6 billion in Q4 2025, and $1.6 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | 1.89 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.89 Bn |
| Mar 31, 2026 | 1.65 Bn |
| Dec 31, 2025 | 1.63 Bn |
| Sep 30, 2025 | 1.60 Bn |
| Jun 30, 2025 | 1.61 Bn |
| Mar 31, 2025 | 1.65 Bn |
| Dec 31, 2024 | 1.65 Bn |
| Sep 30, 2024 | 1.34 Bn |
| Jun 30, 2024 | 1.08 Bn |
| Mar 31, 2024 | 1.13 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 1.20 Bn |
| Jun 30, 2023 | 1.21 Bn |
| Mar 31, 2023 | 1.19 Bn |
| Dec 31, 2022 | 1.19 Bn |
| Sep 30, 2022 | 1.22 Bn |
| Jun 30, 2022 | 1.25 Bn |
| Mar 31, 2022 | 969.11 Mn |
| Dec 31, 2021 | 716.94 Mn |
| Sep 30, 2021 | 727.77 Mn |